Infusion Product Articles & Analysis
12 news found
“To meaningfully impact medication safety, we reimagined the infusion process from beginning to end,” said Susan Niemeier, vice president, clinical excellence and product strategy for infusion systems at Fresenius Kabi. “Every aspect of the Ivenix Infusion System is designed to improve outcomes, prevent ...
Biopsies have not yet been conducted for patient #4 and #5, who have been more recently infused. Darker pigmentation observed may be a sign of multi-functional cystinosin activity post gene therapy Patients with cystinosis frequently exhibit blond or lighter-colored hair and fair complexion because of reduced levels of melanin in their skin. ...
MedCBDX Our team at MedCBDX is on a mission to provide consumers with access to safe CBD products online. Our CBD-infused products are intended to be swiftly absorbed for maximum benefits, with none of the problems or discomforts associated with conventional CBD supplements. MedCBDX is the leading creator of CBD-oil infused ...
ByMedcbdx
The abstract for the poster describes how Obsidian’s cytoTIL15 product (cytoTIL™ therapy engineered with mbIL15) demonstrates enhanced in vivo performance in the absence of IL-2, paving the way for more durable efficacy and improved safety in patients with solid tumor malignancies, and has been published in Molecular Therapy. ...
TIKOMED, a specialty pharmaceutical company developing an infusion product for improving the outcome in cell therapies, today announced that the first patient has been treated in TIKOMED’s ongoing Phase II international, multicenter study – NNCIT-02. In the NNCIT-02 study, brittle diabetes patients being transplanted with islets of Langerhans are ...
” The company has repeatedly demonstrated the value of its platform in an immunotherapy setting, having characterized a CAR-Natural Killer T (NKT) infusion cell therapy product developed at the Baylor College of Medicine for use in neuroblastoma patients. ...
ByImmunai
The new OneDose ReadyfusOR Gen2 comes in a smaller size and with a significant weight reduction compared to the original product. The CE Mark approval demonstrates that BioQ’s OneDose ReadyfusOR Gen2 infusion system is fully compliant with the essential requirements of all relevant European Medical Device Directives related to safety and performance. This ...
Under the agreement, the parties will work together to obtain appropriate regulatory approvals and commercialize self-contained, infusible, non-opioid post-operative pain pharmaceutical product in the United States, Canada and Mexico. Avanos, which established the iconic On-Q brand, brings deep commercial expertise to enable the wide-scale launch of BioQ’s ...
Using the Company’s patented invenious™ technology, the Propofusor is a programmable, ready-to-use, single use infusion pharmaceutical product, which is pre-filled at the point of manufacture with 1% propofol, a hypnotic amnestic agent and the world’s most widely used surgical sedation drug. ...
BioQ Pharma Incorporated (“the Company”), a specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals, today announced the positive closure of a European regulatory procedure for its propofol product. The Company’s ready-to-use infusion pharmaceutical includes the propofol ...
Braun Medical Inc., a leader in infusion therapy and pain management. Intravenous (IV) therapy plays a central role in patient care with as many as 90 percent of hospital patients receiving a peripheral IV catheter as part of their treatment plan. ...
DiF-JET Gas Infusion Systems equipped with floatation for aquaculture applications are also available. ...